DOCSLIB.ORG

Universal Registration Document 2019

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Universal Registration Document 2019 9 Universal Registration Document 2019 ANNUAL FINANCIAL REPORT CERTAIN PRELIMINARY INFORMATION ABOUT THIS ANNUAL REPORT 1 Chairman’s Message 4 Chief Executive Off icer’s Message 5 THE AXA GROUP 13 1.1 Key figures 14 1 1.2 History 19 1.3 Business overview 21 CONTENTS ACTIVITY REPORT AND CAPITAL MANAGEMENT 29 2.1 Market Environment 30 2 2.2 Operating Highlights 35 2.3 Activity report 40 2.4 Liquidity and capital resources 82 2.5 Events subsequent to December 31, 2019 89 2.6 Outlook 90 CORPORATE GOVERNANCE 91 3.1 Corporate governance structure 92 3 3.2 Executive compensation and share ownership 120 3.3 Corporate Governance Code of Reference 152 3.4 Related-party transactions 153 RISK FACTORS AND RISK MANAGEMENT 157 4.1 Risk factors 158 4 4.2 Internal Control and Risk Management 176 4.3 Market risks 190 4.4 Credit risk 197 4.5 Liquidity risk 201 4.6 Insurance risks 202 4.7 Operational risk 206 4.8 Other material risks 207 CONSOLIDATED FINANCIAL STATEMENTS 209 5.1 Consolidated statement of financial position 210 5 5.2 Consolidated statement of income 212 5.3 Consolidated statement of comprehensive income 213 5.4 Consolidated statement of changes in equity 214 5.5 Consolidated statement of cash flows 218 5.6 Notes to the Consolidated Financial Statements 220 5.7 Report of the Statutory Auditors on the consolidated financial statements 366 SHARES, SHARE CAPITAL AND GENERAL INFORMATION 373 6.1 AXA shares 374 6 6.2 Share capital 375 6.3 General Information 380 CORPORATE RESPONSIBILITY 393 7.1 Introduction 394 7 7.2 Social information 401 7.3 Climate change and biodiversity 411 7.4 Inclusive insurer 421 7.5 Business behaviour 426 7.6 Vigilance plan 433 APPENDICES 439 Appendix I Management’s annual evaluation of internal control over financial reporting 440 Appendix II Statement of the person responsible for the Universal Registration Document 443 A Appendix III AXA parent company financial statements 444 Appendix IV Group Embedded Value and Solvency II Own Funds 470 Appendix V Glossary 471 Appendix VI Board of Directors’ report – Cross-reference table 476 Appendix VII Corporate governance report – Cross-reference table 477 Appendix VIII Commission delegated regulation (EU) 2019/980 of March 14, 2019 – Cross-reference table 478 Appendix IX Annual Financial Report – Cross-reference table 482 UNIVERSAL REGISTRATION DOCUMENT ANNUAL REPORT 2019 This Universal Registration Document has been filed on March 19, 2020 with the Autorité des Marchés Financiers (the “AMF”) as the competent authority under Regulation (EU) 2017/1129, without prior approval pursuant to Article 9 of Regulation (EU) 2017/1129. This Universal Registration Document may be used for the purposes of an off er to the public of securities or admission of securities to trading on a regulated market if approved by the AMF together with any amendments, if applicable, and a securities note and summary approved in accordance with Regulation (EU) 2017/1129. This Universal Registration Document (which we also refer to as our “Annual Report”) includes (i) all the components of the Annual Financial Report (Rapport Financier Annuel) referred to in paragraph I of Article L.451-1-2 of the French Monetary and Financial Code (Code monétaire et financier) as well as in Article 222-3 of the AMF General Regulation (Règlement Général de l’AMF) (please refer to the cross-reference table on page 482 of this Universal Registration Document which indicates the relevant sections of this Universal Registration Document corresponding to the items referred to in Article 222-3 of the AMF General Regulation), (ii) all disclosure matters required to be included in the Board of Directors’ Report to AXA’s Shareholders’ Meeting to be held on April 30, 2020, established pursuant to Articles L.225-100 et seq. of the French Commercial Code (Code de commerce) (the relevant sections of this Universal Registration Document corresponding to such required disclosures have been approved by AXA’s Board of Directors and are referred to in the cross-reference table on page 476 of this Universal Registration Document), and (iii) all the elements required to be included in the corporate governance report established pursuant to Articles L.225-37 et seq. of the French Commercial Code (Code de commerce) (the relevant sections of this Universal Registration Document corresponding to such required disclosures have been approved by AXA’s Board of Directors and are referred to in the cross reference table on page 477 of this Universal Registration Document). The cross-reference table on page 478 of this Universal Registration Document indicates the items of Annexes 1 and 2 of Delegated Regulation (EU) 2019/980 to which the information contained herein corresponds. CERTAIN PRELIMINARY INFORMATION ABOUT THIS ANNUAL REPORT In this Annual Report, unless provided otherwise, (i) the published in Euro (“Euro”, “euro”, “EUR” or “€”). Unless otherwise “Company”, “AXA” and “AXA SA” refer to AXA, a société anonyme stated, all amounts in this Annual Report are (i) expressed in Euro, (a public limited company) organized under the laws of France, with applicable foreign exchange rates presented on page 31 of which is the publicly traded parent company of the AXA Group, this Annual Report, and (ii) presented in millions for convenience. and (ii) the “AXA Group”, the “Group” and “we” refer to AXA SA Such amounts may have been rounded. Rounding diff erences together with its direct and indirect consolidated subsidiaries. may exist, including for percentages. The Company’s ordinary shares are referred to in this Annual Where reference is made to a website in this Universal Report as “shares”, “ordinary shares”, “AXA shares” or “AXA Registration Document, the contents of such website do not form ordinary shares”. The principal trading market for AXA’s ordinary part of this Universal Registration Document. No information, shares is the regulated market Euronext in Paris (Compartment A), document or material from the website of the Company which we refer to in this Annual Report as “Euronext Paris”. (www.axa.com) or any other source shall form part of this The Group’s consolidated financial statements and related notes Universal Registration Document, unless such information, are prepared in accordance with International Financial Reporting document or material is expressly incorporated by reference Standards (IFRS) (the “Consolidated Financial Statements”) and into this Universal Registration Document. I UNIVERSAL REGISTRATION DOCUMENT - ANNUAL REPORT 2019 - AXA I 1 This page was intentionally left blank. 2 I UNIVERSAL REGISTRATION DOCUMENT - ANNUAL REPORT 2019 - AXA I Cautionary statement regarding forward-looking statements and the use of non-gaap fi nancial measures This Annual Report may include statements with respect to In addition to the Consolidated Financial Statements, this future events, trends, plans, expectations or objectives and Annual Report refers to certain non-GAAP financial measures, other forward-looking statements relating to the Group’s future or alternative performance measures, used by Management in business, financial condition, results of operations, performance, analyzing the Group’s operating trends, financial performance and strategy. Forward-looking statements are not statements of and financial position and providing investors with additional historical fact and may contain the terms “may”, “will”, “should”, information that Management believes to be useful and “continue”, “aims”, “estimates”, “projects”, “believes”, “intends”, relevant regarding the Group’s results. These non-GAAP financial “expects”, “plans”, “seeks” or “anticipates”, or words of similar measures generally have no standardized meaning and therefore meaning. Such statements are based on Management’s current may not be comparable to similarly labelled measures used by views and assumptions and, by nature, involve known and other companies. As a result, none of these non-GAAP financial unknown risks and uncertainties; therefore, undue reliance measures should be considered in isolation from, or as a should not be placed on them. Actual financial condition, results substitute for, the Consolidated Financial Statements included of operations, performance or events may diff er materially from in Part 5 – “Consolidated Financial Statements” of this Annual those expressed or implied in such forward-looking statements, Report. The non-GAAP financial measures used by the Group due to a number of factors including, without limitation, general are defined in the Glossary set forth in Appendix V to this Annual economic and political conditions and competitive situation; Report. future financial market performance and conditions, including The results of our U.S. segment are presented on the basis of IFRS fluctuations in exchange and interest rates; frequency and and are not, and should not be relied upon as representing, the severity of insured loss events, and increases in loss expenses; U.S. GAAP results of Equitable Holdings, Inc. (“EQH”)(1) (including mortality and morbidity levels and trends; persistency levels; AB), which, as a U.S. public company, reports in U.S. GAAP in changes in laws, regulations and standards; the impact of accordance with the rules of the U.S. Securities and Exchange acquisitions and disposal, including related integration issues, Commission (“SEC”). For further information on EQH’s financial and reorganization measures; and general competitive factors, results and other public reports please consult the SEC website in each
Load more

Recommended publications
  • Online Edition 22 February 2021
    15 March, 2021 – Issue 858 penews.com Online edition 22 February 2021 The news and analysis powering European private equity The Bright Alternative in Fund and Corporate Services If you are launching a fund, looking to outsource, or are considering migrating, we can support you. Please call James Duffield, our Head of Business Development, on +44( 0)20 3818 0250 Explore: aztecgroup.co.uk | .eu Aztec Group is authorised to carry on financial services in the jurisdictions which it operates. 15 March, 2021 – Issue 858 penews.com The Bright Alternative in Fund and Corporate Services If you are launching a fund, looking to outsource, or are considering migrating, we can support you. Please call James Duffield, our Head of Business Development, on +44( 0)20 3818 0250 Explore: aztecgroup.co.uk | .eu Aztec Group is authorised to carry on financial services in the jurisdictions which it operates. www.penews.com • 15 March, 2021 News 3 CONTENTS Charterhouse to sell drugmaker Cover Cooper to CVC in €2.2bn deal Elisângela Mendonça reinvestment” in Cooper and over 35 years of activity. Its main DANILO AGUTOLI DANILO continue to support the growth targets are transactions with an London-based private equity firm and international expansion of the enterprise value of between €75m Charterhouse Capital Partners business alongside CVC, it said. and €1.5bn in services, health- said it has entered into exclusive Headquartered in Paris, Cooper care, specialised industrials and talks with CVC Capital Partners manufactures and distributes a di- consumer sectors. Since 1994, its to sell a majority stake in French versified portfolio of branded and more than 50 investments have l Michael Moore: The BVCA boss and former MP on why private equity drugmaker Cooperation Phar- basic products on an international generated €19.7bn of proceeds at must create public value maceutique Française, known as basis, to 30 export markets.
    [Show full text]
  • OPTIMAL VALUE R Eurozone Value Equity ISIN FR0012144590 MONTHLY REPORT AUGUST 31, 2021
    MANDARINE OPTIMAL VALUE R Eurozone Value Equity ISIN FR0012144590 MONTHLY REPORT AUGUST 31, 2021 Risk profile 1 2 3 4 5 6 7 Mandarine Optimal Value selects eurozone companies with two specific characteristics: stocks that are undervalued by the market and offer an improving financial and extra- financial outlook (positive momentum). +2.7% +24.2% 16.9% Performance Performance Volatility 1 month YTD 1 year PERFORMANCES AND RISKS The data presented relates to past periods, past performance is not an indicator of future results. Bench. Bench. Bench. +2.6% +20.3% 16.9% Statistical indicators are calculated on a weekly basis. Benchmark: EuroStoxx Large NR Evolution since inception 162.13EUR Fund Bench. Net asset value 80% Yohan Florian SALLERON ALLAIN 60% Even if some fears persist regarding the pace of future growth (thereby favouring stocks with 40% generally defensive profiles over the month), the eurozone stock markets pursued their rebounds, 20% consequently showing solid annual gains. 0% As could be expected, the best contributors to the fund’s performance over the month included -20% healthcare (Merck, Eurofins scientific) and public 2015 2016 2017 2018 2019 2020 2021 services (Verbund). Our luxury goods stocks (LVMH, Moncler and Kering) suffered in August due to Chinese Annual performances statements evoking the idea of a better distribution of wealth in China. Fund Bench. 30% Despite the rather cyclical bias in our portfolio, +26.5 +24.2 which we are maintaining due to these stocks’ +20.3 +16.3 good financial momentum (which is not 15% +12.3 +10.8 weakening), the fund nevertheless succeeded in +6.2 slightly outperforming its benchmark index over +4.0 the month, thereby adding to its cumulative 0% outperformance since the beginning of the year.
    [Show full text]
  • Liste Des Actions Concernées Par L'interdiction De Positions Courtes Nettes
    Liste des actions concernées par l'interdiction de positions courtes nettes L’interdiction s’applique aux actions listées sur une plate-forme française et relevant de la compétence de l’AMF au titre du règlement 236/2012 (information disponible dans les registres ESMA). Cette liste est fournie à titre informatif. L'AMF n'est pas en mesure de garantir que le contenu disponible est complet, exact ou à jour. Compte tenu des diverses sources de données sous- jacentes, des modifications pourraient être apportées régulièrement. Isin Nom FR0010285965 1000MERCIS FR0013341781 2CRSI FR0010050773 A TOUTE VITESSE FR0000076887 A.S.T. GROUPE FR0010557264 AB SCIENCE FR0004040608 ABC ARBITRAGE FR0013185857 ABEO FR0012616852 ABIONYX PHARMA FR0012333284 ABIVAX FR0000064602 ACANTHE DEV. FR0000120404 ACCOR FR0010493510 ACHETER-LOUER.FR FR0000076861 ACTEOS FR0000076655 ACTIA GROUP FR0011038348 ACTIPLAY (GROUPE) FR0010979377 ACTIVIUM GROUP FR0000053076 ADA BE0974269012 ADC SIIC FR0013284627 ADEUNIS FR0000062978 ADL PARTNER FR0011184241 ADOCIA FR0013247244 ADOMOS FR0010340141 ADP FR0010457531 ADTHINK FR0012821890 ADUX FR0004152874 ADVENIS FR0013296746 ADVICENNE FR0000053043 ADVINI US00774B2088 AERKOMM INC FR0011908045 AG3I ES0105422002 AGARTHA REAL EST FR0013452281 AGRIPOWER FR0010641449 AGROGENERATION CH0008853209 AGTA RECORD FR0000031122 AIR FRANCE -KLM FR0000120073 AIR LIQUIDE FR0013285103 AIR MARINE NL0000235190 AIRBUS FR0004180537 AKKA TECHNOLOGIES FR0000053027 AKWEL FR0000060402 ALBIOMA FR0013258662 ALD FR0000054652 ALES GROUPE FR0000053324 ALPES (COMPAGNIE)
    [Show full text]
  • Report Profundo
    Eerlijke Verzekeringswijzer Dutch Fair Insurance Guide A Case Study on Transparency & Accountability A research paper for Amnesty International, Dierenbescherming, FNV, Milieudefensie, Oxfam Novib and PAX Eerlijke Verzekeringswijzer Dutch Fair Insurance Guide A Case Study on Transparency & Accountability A research paper for Amnesty International, Dierenbescherming, FNV, Milieudefensie, Oxfam Novib and PAX Date of publication 5 July 2016 Hester Brink, Retno Kusumaningtyas, Michel Riemersma, Joeri de Wilde Naritaweg 10 1043 BX Amsterdam The Netherlands Tel: +31-20-8208320 E-mail: [email protected] Website: www.profundo.nl Contents Samenvatting ............................................................................................................ i Summary ......................................................................................................... vii Introduction ........................................................................................................... 1 Chapter 1 Background ...................................................................................... 3 1.1 What is at stake? ....................................................................................... 3 1.2 Themes ...................................................................................................... 4 1.2.1 Organisation................................................................................................ 4 1.2.2 Policy .........................................................................................................
    [Show full text]
  • No Politics Without Culture !
    2013 CULTURE & POWER NO POLITICS WITHOUT CULTURE ! 2013 CULTURE & Contents POWER PRODUCE The Think tank 04 BROADCAST The International Meetings 06 Publications 08 Team 10 With a turnover of $2 700 billion world- wide, 6.1% of global GDP, 8 million jobs and 4% of GDP in Europe for culture and creative industries: can governments and companies prepare forward-looking strategies without culture? As budget drops have led governments to cut funding for culture across Europe, China has increased its spending by more than 23%. Digital technology is increasing access to artistic productions in India and across Africa. The Middle Eastern nations are investing more and more in culture across the board. Are we witnes- sing a global power shift in Culture? aurÉLIE FILIPpetti (France) Marjane Satrapi (Iran) NEELIE KROES (Netherlands) French Minister of Culture and Communication Cartoonist and Film Director Vice President digital strategy, European Commission " CULTURAL COMMITMENT IS TO BE TOTALLY Renaud CAPUÇON (France) RETHOUGHT " Violonist Axel Dauchez, President of Deezer - ArteTV JT, 2012 ELIE BARNAVI (Romania) Historian and Scientific Director of the Museum of Europe VIVIANNE REDING (Luxembourg) Vice President, European Commission MORE THAN " IF WE SUccEED christine albanel (France) Former French Minister of Culture and Communi- IN CONVINCING PUBLIC cation - Executive Vice President, Communication, 1000 Philanthropy, Content Strategy, Orange AUTHORITIES, FIRMS PARTICIPANTS PER YEAR AND CITIZENS THAT THESE STAKES ARE AT THE VERY HEART OF OUR ECONOMY,
    [Show full text]
  • Actions Synthétiques France Heures De Négociation : 9:00 - 17:30 (CET) Frais Et Commissions : 0.1% Du Montant De La Transaction, Min
    Actions Synthétiques France Heures de négociation : 9:00 - 17:30 (CET) Frais et Commissions : 0.1% du montant de la transaction, min. 8 EUR (Marge sur commission: 70% - 99.9%). Symbole Instrument dont le prix est basé sur Nombre d'actions par lot Taille minimale d'un ordre en lots Vente à découvert Taux d'emprunt de titre (%) AC.FR Accor SA CFD 1 1 OUI -3 ACA.FR Credit Agricole SA CFD 1 1 OUI -3 ADP.FR Aeroports de Paris CFD 1 1 OUI -3 AF.FR Air France-KLM CFD 1 1 OUI -3 AI.FR Air Liquide SA CFD 1 1 OUI -3 AIR.FR Airbus Group NV CFD 1 1 NON - AKE.FR Arkema SA CFD 1 1 OUI -3 ALO.FR Alstom SA CFD 1 1 OUI -3 ALT.FR Altran Technologies SA CFD 1 1 OUI -3 ATO.FR AtoS CFD 1 1 OUI -3 BB.FR Societe BIC SA CFD 1 1 OUI -3 BIM.FR BioMerieux CFD 1 1 OUI -3 BN.FR Danone CFD 1 1 OUI -3 BNP.FR BNP Paribas CFD 1 1 OUI -3 BOL.FR Bollore SA CFD 1 1 OUI -3 BVI.FR Bureau Veritas SA CFD 1 1 OUI -3 CA.FR Carrefour SA CFD 1 1 OUI -3 CAP.FR Cap Gemini SA CFD 1 1 OUI -3 CGG.FR CGG SA CFD 1 1 NON - CNP.FR CNP Assurances CFD 1 1 OUI -3 CO.FR Casino Guichard Perrachon SA CFD 1 1 OUI -3 COFA.FR Coface SA CFD 1 1 OUI -4,5 CS.FR AXA SA CFD 1 1 OUI -3 DEC.FR JCDecaux SA CFD 1 1 OUI -3 DG.FR Vinci SA CFD 1 1 OUI -3 DSY.FR Dassault Systemes CFD 1 1 OUI -3 EDEN.FR Edenred CFD 1 1 OUI -3 EDF.FR EDF SA CFD 1 1 OUI -3 EI.FR Essilor International SA CFD 1 1 OUI -3 ELE.FR Euler Hermes Group CFD 1 1 OUI -4,5 EN.FR Bouygues SA CFD 1 1 OUI -3 ENGI.FR ENGIE CFD 1 1 OUI -3 ENX.FR Euronext NV CFD 1 1 OUI -3 EO.FR Faurecia CFD 1 1 OUI -3 ERA.FR Eramet CFD 1 1 OUI -5 ERF.FR Eurofins
    [Show full text]
  • BIODIVERSITY STRATEGY Bending the Curve on Biodiversity Loss KERING BIODIVERSITY STRATEGY
    BIODIVERSITY STRATEGY Bending the Curve on Biodiversity Loss KERING BIODIVERSITY STRATEGY FOREWORD “How we solve the ongoing environmental crisis is likely the biggest challenge facing our generation. Given the scale of biodiversity loss sweeping the planet, we must take bold action. As businesses, we need to safeguard nature within our own supply chains, as well as champion transformative actions far beyond them to ensure that humanity operates within planetary boundaries. At Kering, our Houses’ products begin their lives in farms, fields, forests and other ecosystems around the world. The careful stewardship of these landscapes is fundamental to our continued success, and also linked to our responsibility on a broader global scale. With Kering’s biodiversity strategy, we are proud to put forth concrete targets to play our part in bending the curve on biodiversity loss, and helping to chart a course for our industry.” François-Henri Pinault Chief Executive Officer, Kering 1 KERING BIODIVERSITY STRATEGY CONTENTS Our Planet In Peril – p.03 Our Commitment – p.04 A Paradigm Shift – p.05 Taking Stock of Progress at Kering – p.06 Taking Action: Aligning To The Science Based Targets Network – p.07 Value Chain Mapping & Materiality Assessments – p.08 Environmental Profit & Loss (EP&L) Accounting – p.09 The Biodiversity Impact Metric – p.09 The Guiding Framework Stage 1: Avoid – p.10 Stage 2: Reduce – p.13 Stage 3: Restore & Regenerate – p.16 Stage 4: Transform – p.20 Monitoring, Reporting & Verification– p.23 Final Thoughts – p.23 References – p.24 Acknowledgements We wish to thank the many external reviewers who provided critical feedback to strengthen this strategy.
    [Show full text]
  • I AXA Group Solvency Ratio
    REGISTRATION DOCUMENT ANNUAL FINANCIAL REPORT 2016 CERTAIN PRELIMINARY INFORMATION ABOUT THIS ANNUAL REPORT 1 Group profi le 4 Chairman and Chief Executive Offi cer’s messages 6 THE AXA GROUP 9 1.1 Key fi gures 11 1.2 History 15 1 1.3 Business overview 17 CONTENTS ACTIVITY REPORT AND CAPITAL MANAGEMENT 27 2.1 Market environment 28 2.2 Operating Highlights 33 2 2.3 Activity Report 38 2.4 Liquidity and capital resources 93 2.5 Events subsequent to December 31, 2016 100 2.6 Outlook 101 CORPORATE GOVERNANCE 103 3.1 Corporate governance structure – A balanced and effi cient governance 104 3.2 Executive compensation and share ownership 136 3 3.3 Related-party transactions 171 RISK FACTORS AND RISK MANAGEMENT 177 4.1 Risk factors 178 4.2 Internal control and risk management 190 4 4.3 Market risks 204 4.4 Credit risk 211 4.5 Liquidity risk 214 4.6 Insurance risks 215 4.7 Operational risk 219 4.8 Other material risks 220 CONSOLIDATED FINANCIAL STATEMENTS 223 5.1 Consolidated statement of fi nancial position 224 5.2 Consolidated statement of income 226 5 5.3 Consolidated statement of comprehensive income 227 5.4 Consolidated statement of changes in equity 228 5.5 Consolidated statement of cash fl ows 232 5.6 Notes to the Consolidated Financial Statements 234 5.7 Report of the Statutory Auditors on the consolidated fi nancial statements 370 SHARES, SHARE CAPITAL AND GENERAL INFORMATION 373 6.1 AXA shares 374 6.2 Share capital 375 6 6.3 General information 381 CORPORATE RESPONSIBILITY 391 7.1 General information 392 7.2 Social information 393 7 7.3 Environmental
    [Show full text]
  • Permanent Information on Executive Officers’ Compensation
    February 26, 2021 PERMANENT INFORMATION ON EXECUTIVE OFFICERS’ COMPENSATION In accordance with the Afep-Medef Corporate governance code, AXA hereby discloses decisions made by its Board of Directors on February 24, 2021 with respect to the compensation of AXA’s executive officers. Variable compensation of the Chief Executive Officer (CEO) for 2020 The variable compensation of Mr. Buberl (CEO) is based on two components: The Group performance and his individual performance, which are assessed separately. The determination of the CEO’s variable compensation is based on the following formula: Variable compensation due = Target variable compensation * (70% Group Performance + 30% Individual Performance). Group Performance component In determining the Group performance component of Mr. Buberl’s variable compensation, the Compensation & Governance Committee and the Board of Directors considered the results of the calculation defined at the beginning of the year applicable to all senior executives and based on the following indicators: (i) underlying earnings per share; (ii) adjusted Return on Equity (RoE); (iii) gross revenues, both in Commercial Property & Casualty and in Protection and Health; (iv) Net Promoter Score (customer recommendation index) and (v) non-commission expenses which respectively weigh 55%, 15%, 10%, 10% and 10%. The results of the calculation were significantly impacted by the Covid-19 crisis. Given the demanding nature of the objectives, the strict application of the formula determined by the Board of Directors at the beginning of 2020 to assess the Group performance sets the global achievement rate of these objectives at 35%. A complete neutralization of the impact of the sanitary crisis (1.5 billion euros on the 2020 underlining earnings) would set the global achievement rate of the Group performance at 68%.
    [Show full text]
  • Factset-Top Ten-0521.Xlsm
    Pax International Sustainable Economy Fund USD 7/31/2021 Port. Ending Market Value Portfolio Weight ASML Holding NV 34,391,879.94 4.3 Roche Holding Ltd 28,162,840.25 3.5 Novo Nordisk A/S Class B 17,719,993.74 2.2 SAP SE 17,154,858.23 2.1 AstraZeneca PLC 15,759,939.73 2.0 Unilever PLC 13,234,315.16 1.7 Commonwealth Bank of Australia 13,046,820.57 1.6 L'Oreal SA 10,415,009.32 1.3 Schneider Electric SE 10,269,506.68 1.3 GlaxoSmithKline plc 9,942,271.59 1.2 Allianz SE 9,890,811.85 1.2 Hong Kong Exchanges & Clearing Ltd. 9,477,680.83 1.2 Lonza Group AG 9,369,993.95 1.2 RELX PLC 9,269,729.12 1.2 BNP Paribas SA Class A 8,824,299.39 1.1 Takeda Pharmaceutical Co. Ltd. 8,557,780.88 1.1 Air Liquide SA 8,445,618.28 1.1 KDDI Corporation 7,560,223.63 0.9 Recruit Holdings Co., Ltd. 7,424,282.72 0.9 HOYA CORPORATION 7,295,471.27 0.9 ABB Ltd. 7,293,350.84 0.9 BASF SE 7,257,816.71 0.9 Tokyo Electron Ltd. 7,049,583.59 0.9 Munich Reinsurance Company 7,019,776.96 0.9 ASSA ABLOY AB Class B 6,982,707.69 0.9 Vestas Wind Systems A/S 6,965,518.08 0.9 Merck KGaA 6,868,081.50 0.9 Iberdrola SA 6,581,084.07 0.8 Compagnie Generale des Etablissements Michelin SCA 6,555,056.14 0.8 Straumann Holding AG 6,480,282.66 0.8 Atlas Copco AB Class B 6,194,910.19 0.8 Deutsche Boerse AG 6,186,305.10 0.8 UPM-Kymmene Oyj 5,956,283.07 0.7 Deutsche Post AG 5,851,177.11 0.7 Enel SpA 5,808,234.13 0.7 AXA SA 5,790,969.55 0.7 Nintendo Co., Ltd.
    [Show full text]
  • Euro Stoxx® Multi Premia Index
    EURO STOXX® MULTI PREMIA INDEX Components1 Company Supersector Country Weight (%) SARTORIUS STEDIM BIOTECH Health Care France 1.59 IMCD Chemicals Netherlands 1.25 VOPAK Industrial Goods & Services Netherlands 1.15 BIOMERIEUX Health Care France 1.04 REMY COINTREAU Food, Beverage & Tobacco France 1.03 EURONEXT Financial Services France 1.00 HERMES INTERNATIONAL Consumer Products & Services France 0.94 SUEZ ENVIRONNEMENT Utilities France 0.94 BRENNTAG Chemicals Germany 0.93 ENAGAS Energy Spain 0.90 ILIAD Telecommunications France 0.89 DEUTSCHE POST Industrial Goods & Services Germany 0.88 FUCHS PETROLUB PREF Chemicals Germany 0.88 SEB Consumer Products & Services France 0.87 SIGNIFY Construction & Materials Netherlands 0.86 CARL ZEISS MEDITEC Health Care Germany 0.80 SOFINA Financial Services Belgium 0.80 EUROFINS SCIENTIFIC Health Care France 0.80 RATIONAL Industrial Goods & Services Germany 0.80 AALBERTS Industrial Goods & Services Netherlands 0.74 KINGSPAN GRP Construction & Materials Ireland 0.73 GERRESHEIMER Health Care Germany 0.72 GLANBIA Food, Beverage & Tobacco Ireland 0.71 PUBLICIS GRP Media France 0.70 UNITED INTERNET Technology Germany 0.70 L'OREAL Consumer Products & Services France 0.70 KPN Telecommunications Netherlands 0.68 SARTORIUS PREF. Health Care Germany 0.68 BMW Automobiles & Parts Germany 0.68 VISCOFAN Food, Beverage & Tobacco Spain 0.67 SAINT GOBAIN Construction & Materials France 0.67 CORBION Food, Beverage & Tobacco Netherlands 0.66 DAIMLER Automobiles & Parts Germany 0.66 PROSIEBENSAT.1 MEDIA Media Germany 0.65
    [Show full text]
  • Is the Cac 40 Responsible?
    IS THE CAC 40 RESPONSIBLE? ENGAGEMENT REPORT ANNUAL GENERAL MEETINGS 2020 MORE EFFORTS TO BE MADE Faced with the challenges of our time – climate change, the collapse of biodiversity, the global growth in inequality – the social responsibility of companies and investors is considerable. Responsible investors have a role to play in engaging in a constructive dialogue with companies on key issues that affect their future as well as that of their stakeholders. For this reason, in 2020, the FIR launched its first campaign of written questions, which were submitted to the general meetings of CAC 40 companies. Large companies not only have an impact on the economy but also on the environment and on the social equilibrium of the countries in which they operate. The FIR has therefore chosen to conduct this campaign with the CAC 40 by acquiring one share of each company on the CAC 40. While the FIR’s stock portfolio remains modest, the members of its “Dialogue and Engagement Commission” manage over €4,500 billion in assets, which is somewhat less so. In this campaign, which included 12 questions1 on 12 major social responsibility themes, our assessments were guided by the quality of the response and the seriousness with which companies answered. Although our analyses of the responses are necessarily subjective to a certain extent, this report is based on meticulous work carried out by a group of ESG analysis professionals, based on a detailed and shared analysis grid. We can say straight away that the answers we received did not live up to our expectations.
    [Show full text]